Requirements for success in clinical islet transplantation

Transplantation

Volumn 79, Issue 10, 2005, Pages 1298-1300

  Ricordi, Camillo ^a,b,d,e   Inverardi, Luca ^a   Kenyon, Norma S ^a   Goss, John ^c   Bertuzzi, Federico ^b   Alejandro, Rodolfo ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d Division of Cellular Transplantation   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Graft loss; Islet culture; Islet isolation; Islet transplantation; Tolerance

Indexed keywords

ANTIGENICITY; CHRONIC GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MONITORING; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; TREATMENT FAILURE;

DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; TREATMENT OUTCOME;

EID: 19544368131     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000157275.64874.84     Document Type: Review

References (19)

1. Ricordi C. Islet transplantation: a brave new world. Diabetes 2003; 52: 1595.
2. Ricordi C, Strom TB. Clinical islet transplantation: advances and immunological challenges. Nat Rev Immunol 2004; 4: 259.
3. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148.
4. Goss JA, Goodpastor SE, Brunicardi FC, et al. Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center. Transplantation 2004; 77:462.
5. Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004; 4: 390.
6. Ricordi C, Fraker C, Szust J, et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003; 75: 1524.
7. Shapiro AM, Ricordi C. Unraveling the secrets of single donor success in islet transplantation. Am J Transplant 2004; 4: 295.
8. Shapiro AM, Ricordi C, Hering B. Edmonton's islet success has indeed been replicated elsewhere. Lancet 2003; 362: 1242.
9. Shapiro AM, Hering B, Ricordi C, et al. International multicenter trial of islet transplantation using the Edmonton Protocol in patients with type 1 diabetes. Am J Transplant 2003; 3(Suppl 5): 152.
10. Kaufman DB, Platt JL, Rabe FL, et al. Differential roles of Mac-1 + cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med 1990; 172; 291.
11. Brandhorst D, Hammes HP, Brandhorst H, et al. Pretransplant induction of HSP-70 in isolated adult pig islets decreases early islet xenograft survival. Cell Transplant 2000; 9: 423.
12. Inverardi L, Kenyon NS, Ricordi C. Islet transplantation: immunological perspectives. Curr Opin Immunol 2003; 15: 507.
13. Ruggles JA, Kelemen D, Baron A. Emerging therapies: controlling glucose homeostasis, immunotherapy, islet transplantation, gene therapy, and islet cell neogenesis and regeneration. Endocrinol Metab Clin North Am 2004; 33: 239.
14. Tsujimura T, Kuroda Y, Kin T, et al. Human islet transplantation from pancreases with prolonged cold ischemia using additional preservation by the two-layer (UW solution/perfluorochemical) cold-storage method. Transplantation. 2002; 74: 1687.
15. Moberg L, Olsson A, Berne C, et al. Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation. Transplantation 2003; 76: 1285.
16. Bottino R, Fernandez LA, Ricordi C, et al. Transplantation of allogeneic islets of Langerhans in the rat liver. Effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998; 47: 316.
17. Piemonti L, Leone BE, Nano R, et al. Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 2002; 51: 55.
18. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039.
19. Ricordi C, Lacy PE, Sterbenz K, et al. Low temperature culture of human islets or in-vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Proc Nat Acad Sci USA 1987; 84: 8080.